CA2039159A1 - Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procedes de diagnostic des infections a hhv6 - Google Patents
Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procedes de diagnostic des infections a hhv6Info
- Publication number
- CA2039159A1 CA2039159A1 CA002039159A CA2039159A CA2039159A1 CA 2039159 A1 CA2039159 A1 CA 2039159A1 CA 002039159 A CA002039159 A CA 002039159A CA 2039159 A CA2039159 A CA 2039159A CA 2039159 A1 CA2039159 A1 CA 2039159A1
- Authority
- CA
- Canada
- Prior art keywords
- hhv6
- dna
- plasmid
- sequence
- sie
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012634 fragment Substances 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims description 15
- 238000003745 diagnosis Methods 0.000 title claims description 7
- 208000015181 infectious disease Diseases 0.000 title claims description 6
- 108020004414 DNA Proteins 0.000 claims abstract description 37
- 241000701027 Human herpesvirus 6 Species 0.000 claims abstract description 33
- 241000700605 Viruses Species 0.000 claims abstract description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 9
- 230000029087 digestion Effects 0.000 claims abstract description 9
- 230000000295 complement effect Effects 0.000 claims abstract description 8
- 108020004511 Recombinant DNA Proteins 0.000 claims abstract 4
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract 2
- 239000013612 plasmid Substances 0.000 claims description 23
- 239000003153 chemical reaction reagent Substances 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 14
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 239000000523 sample Substances 0.000 claims description 11
- 230000003321 amplification Effects 0.000 claims description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108091034117 Oligonucleotide Proteins 0.000 claims description 9
- 244000005700 microbiome Species 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 239000012472 biological sample Substances 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 238000005215 recombination Methods 0.000 claims 1
- 230000006798 recombination Effects 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract description 2
- 210000001236 prokaryotic cell Anatomy 0.000 abstract description 2
- 150000007523 nucleic acids Chemical group 0.000 description 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 241000575946 Ione Species 0.000 description 2
- LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000030538 Thecla Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
- C12N2710/16522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8911016 | 1989-08-18 | ||
| FR8911016A FR2651007B1 (fr) | 1989-08-18 | 1989-08-18 | Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procede de diagnostic des infections a hhv6 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2039159A1 true CA2039159A1 (fr) | 1991-02-19 |
Family
ID=9384795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002039159A Abandoned CA2039159A1 (fr) | 1989-08-18 | 1990-08-17 | Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procedes de diagnostic des infections a hhv6 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5545520A (enExample) |
| EP (2) | EP0688874A2 (enExample) |
| JP (1) | JPH04504803A (enExample) |
| AT (1) | ATE135404T1 (enExample) |
| CA (1) | CA2039159A1 (enExample) |
| DE (1) | DE69025907T2 (enExample) |
| FR (1) | FR2651007B1 (enExample) |
| WO (1) | WO1991002794A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE235553T1 (de) * | 1991-07-08 | 2003-04-15 | Dade Behring Marburg Gmbh | Protein p100von menschlichem herpesvirus typ 6, die korrespondierenden dns squenzen, ihre herstellung und verwendung |
| AUPP605298A0 (en) * | 1998-09-21 | 1998-10-15 | Westmead Institute Of Health Research | Detection of human herpes virus 6 (hhv6) |
| KR100460747B1 (ko) * | 2002-09-09 | 2004-12-08 | 주식회사 바이오메드랩 | 인체포진 바이러스의 프로브, 이를 이용한 인체포진바이러스의 유전형 분석용 키트 및 유전형 분석방법 |
| US8405379B1 (en) | 2008-09-18 | 2013-03-26 | Luc Montagnier | System and method for the analysis of DNA sequences in biological fluids |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8706823A1 (es) * | 1985-03-28 | 1987-06-16 | Cetus Corp | Un procedimiento para detectar la presencia o ausencia de al menos una secuencia especifica de acidos nucleicos en una muestra |
| US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| AU615882B2 (en) * | 1986-08-12 | 1991-10-17 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Molecular cloning and clones of human b lymphotropic virus (hblv) |
| DE3852762D1 (de) * | 1987-06-01 | 1995-02-23 | Baylor College Medicine | Expression der immunoaktiven proteine von menschlichem b-lymphotropikvirus. |
-
1989
- 1989-08-18 FR FR8911016A patent/FR2651007B1/fr not_active Expired - Lifetime
-
1990
- 1990-08-17 EP EP95112386A patent/EP0688874A2/fr not_active Withdrawn
- 1990-08-17 JP JP2512026A patent/JPH04504803A/ja active Pending
- 1990-08-17 CA CA002039159A patent/CA2039159A1/fr not_active Abandoned
- 1990-08-17 EP EP90912921A patent/EP0440772B1/fr not_active Expired - Lifetime
- 1990-08-17 AT AT90912921T patent/ATE135404T1/de not_active IP Right Cessation
- 1990-08-17 WO PCT/FR1990/000618 patent/WO1991002794A1/fr not_active Ceased
- 1990-08-17 DE DE69025907T patent/DE69025907T2/de not_active Expired - Fee Related
-
1993
- 1993-09-07 US US08/161,339 patent/US5545520A/en not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/478,141 patent/US5698392A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04504803A (ja) | 1992-08-27 |
| WO1991002794A1 (fr) | 1991-03-07 |
| EP0688874A3 (enExample) | 1996-01-03 |
| US5698392A (en) | 1997-12-16 |
| US5545520A (en) | 1996-08-13 |
| ATE135404T1 (de) | 1996-03-15 |
| FR2651007B1 (fr) | 1992-09-04 |
| EP0440772B1 (fr) | 1996-03-13 |
| EP0440772A1 (fr) | 1991-08-14 |
| DE69025907T2 (de) | 1996-10-02 |
| FR2651007A1 (fr) | 1991-02-22 |
| EP0688874A2 (fr) | 1995-12-27 |
| DE69025907D1 (de) | 1996-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Westphal | SV40 DNA strand selection by Escherichia coli RNA polymerase | |
| Gibello et al. | Development of a PCR assay for detection of Yersinia ruckeri in tissues of inoculated and naturally infected trout | |
| Macnish et al. | A molecular phylogeny of nuclear and mitochondrial sequences in Hymenolepis nana (Cestoda) supports the existence of a cryptic species | |
| KR101501414B1 (ko) | 노로바이러스 검출을 위한 등온증폭 반응용 프라이머 및 이를 이용한 노로바이러스 검출 방법 | |
| Sukhumsirichart et al. | Characterization and PCR detection of hepatopancreatic parvovirus (HPV) from Penaeus monodon in Thailand | |
| Grabherr et al. | The DNA polymerase gene from chlorella viruses PBCV-1 and NY-2A contains an intron with nuclear splicing sequences | |
| EP0803578B1 (en) | Kit for amplification and detection of nucleic acid of cytomegalovirus (cmv) utilizing a nucleic acid sequence (ss2.7) | |
| EP0461045B1 (fr) | Détection spécifique du mycobacterium tuberculosis | |
| Toth et al. | A one step PCR‐based method for the detection of economically important soft rot Erwinia species on micropropagated potato plants | |
| CA2039159A1 (fr) | Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procedes de diagnostic des infections a hhv6 | |
| Stothard et al. | Genetic diversity and genetic exchange in Trypanosoma cruzi: dual drug-resistant" progeny" from episomal transformants | |
| KR102240362B1 (ko) | 유전자 변형 면화 검출용 멀티플렉스 pcr 프라이머 및 이의 용도 | |
| Drohan et al. | Distribution of Mason-Pfizer virus-specific sequences in the DNA of primates | |
| Cafarchia et al. | Physiological and molecular characterization of atypical lipid-dependent Malassezia yeasts from a dog with skin lesions: adaptation to a new host? | |
| Phung et al. | Genetic analyses of feline foamy virus isolates from domestic and wild feline species in geographically distinct areas | |
| JP7274164B2 (ja) | ストレプトコッカス ミュータンスの検出方法 | |
| Tseng et al. | Bacteriophage T4 nrdA and nrdB genes, encoding ribonucleotide reductase, are expressed both separately and coordinately: characterization of the nrdB promoter | |
| CN101864423A (zh) | 决定仔猪F4ac腹泻易感/抗性的MUC13基因及其应用 | |
| EP0580621B1 (fr) | Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile | |
| Tagliavini et al. | Mitochondrial DNA variability in Anguilla anguilla and phylogenetical relationships with congeneric species | |
| JP5548389B2 (ja) | ビソクラミス属に属する菌類の検出方法 | |
| Varghese et al. | Evolutionary implications of nucleotide sequence relatedness between Alnus nepalensis and Alnus glutinosa and also between corresponding Frankia microsymbionts | |
| CN119331990B (zh) | Il-15基因上一种与猪低背膘厚、高肌内脂肪含量相关的snp分子标记及其应用 | |
| KR100639834B1 (ko) | 파이토퓨쏘라 인페스탄스의 ａ1 교배형 균주 검출용ｄｎａ 분자표지인자 | |
| EP0618982B1 (en) | Probe for aeromonas salmonicida and the use thereof in methods of detecting or determining the organism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |